5-[3-(Tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride

CAS: 27912-14-7

Ref. 3D-FL30658

Informação sobre produto

• Nome: 5-[3-(Tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride
• Sinónimos: Levobunolol HCL, (2S)-N-tert-butyl-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride, (S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride, 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1), 1(2H)-Naphthalenone, 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (-)-, 1(2H)-Naphthalenone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (S)-, Ag 901, Betagan, Gotensin, Levobunolol Hydrochloride, N-tert-butyl-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride, Vitagan, W 7000A, l-Bunolol hydrochloride

Descrição

Dorzolamide hydrochloride is an anti-pcsk9 antibody that has been used in the treatment of various eye disorders such as glaucoma, ocular hypertension, and open-angle glaucoma. It is a competitive inhibitor of the pcsk9 protein, which inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) activity. Levobunolol is a beta-blocker that has been used to treat eye disorders such as glaucoma and ocular hypertension. It acts by blocking alpha-receptors in the eye, which decreases the production of aqueous humor. Dorzolamide hydrochloride has also been shown to inhibit bacterial growth at concentrations of 0.5 mg/mL or higher when tested with antimicrobial agents against Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli organisms. In addition, it can be detected

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 327.85 g/mol
• Fórmula: C₁₇H₂₅NO₃·HCl
• Pureza: Min. 95%